Enzyme Points Way to Pacemaker Drug

Researchers have identified an enyzme that slows heart rate after an adrenaline boost, raising the possibility of replacing current implanted pacemakers with a drug.

Illustration of a Bohr atom model spinning around the words Science Quickly with various science and medicine related icons around the text

Join Our Community of Science Lovers!


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.



A heart beats three billion times in an average life span – and sometimes those beats race, like when we run into a Grizzly bear or climb stairs or fall in love. Such moments can more than double the average heart rate of 70 beats per minute, speeding it up to 160 beats. And we feel it. Palpitations, dizziness, breathlessness.

Scientists have a good idea what causes a racing heart: an increase in adrenaline sends a signal to the pacemaker cell, located in the upper right chamber. This cell then sets off a domino effect that speeds up the muscle contractions. What scientists don't understand, though, is what makes the heart beat slow back down.  But a team at the University of Illinois at Chicago says they've found a promising clue. They've isolated an enzyme called "P-21 activated kinase," or Pak 1, that affects the electrical channels inside the pacemaker cell.  The scientists have shown that by turning on Pak 1 they can reduce electrical channel activity and slow down the heart.  They're now working on finding a drug treatment that can control this enzyme, hoping that a medicine might replace artificial pacemakers.  Be still my beating heart.

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe